Joseph Michael Fitzgerald, EVP & Group President, Cardiology at BOSTON SCIENTIFIC CORP (BSX), sold 14,467 shares at $89.97 ($1.5M) on 2024-12-10, disclosed to the SEC on 2025-02-13.
Tax-driven sale ($1.5M) by EVP & Group President, Cardiology — typically RSU/option vesting with shares sold to cover withholding tax. Not a directional view.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.97 | 20 | $2K | 0.1% |
| 2 | $105.98 | 14,447 | $1.5M | 99.9% |
| Total | $105.96 avg | 14,467 | $1.5M | 100% |
| Filing → |
| BSX | SELL | 2025-09-03 | $10.5M | — | Filing → |
| BSX | SELL | 2025-08-04 | $5.2M | — | Filing → |
| BSX | SELL | 2025-07-02 | $5.3M | — | Filing → |